Disclosure: Dr. Arnold has received research funding from Shire, Supernus, Otsuka, Roche /Genentech, and YoungLiving, has consulted with Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), Pfizer , and Waypoint, and has been on advisory boards for Ironshore, Novartis , Otsuka, Pfizer, Roche, and Shire (a Takeda company). Dr. Arns is unpaid research director of the Brainclinics Foundation, a minority shareholder in neuroCare Group (Munich, Germany); Brainclinics Foundation has received research funding from NIMH, Brain Resource (Sydney, Australia), UrgoTech and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn and Magventure. Dr. Barterian has received royalties from Springer Nature. Dr. Dasgupta has operated an integrative medicine clinic in Asheville, NC. Dr. deBeus has received research funding from NIMH, has served on the Board of Directors for the International Society for Neurofeedback and Research, and has a clinic in NC where he performs neurofeedback among other clinical services. Dr. Hirshberg is the Owner and Director of the NeuroDevelopment Center, Inc., which provides neurofeedback and other psychological services. Dr. Hollway has received research funding from F. Hoffman-La Roche, Supernus Pharmaceuticals, Young Living, the National Institutes of Health (NIH), and Autism Speaks. She has served on the YAMO Pharmaceuticals advisory board and has consulted with MedAvante-ProPhase for Finch Therapeutics. Dr. Kerson is Founder, CEO, and Director of Applied Psychophysiology Education (APEd). Dr. McBurnett has received research funding from Otsuka American Pharmaceutical, Akili Interactive, and American Bri-Vision and has served on the speakers’ bureau for Ironshore. Dr. Monastra is the co-developer of the Thought Technology ADHD Assessment Suite and director of the FPI Attention Disorders Clinic. He has received equipment grants from Thought Technology and royalties from the Biofeedback Federation of Europe. He has received royalties for books and professional training videos on diagnosing and treating ADHD from the American Psychological Association. Dr. Roley-Roberts has received research funding from the American Psychological Foundation , the Foundation for Education and Research in Biofeedback and Related Sciences, the Foundation for Neurofeedback and Neuromodulation Research, NIMH, and NIH. Mr. Lightstone is founder and owner of EEG Software LLC. Drs. Black, Lofthouse, Lubar, Pan, Rice, Schrader, Williams, Mss. Bergman, Connor, Higgins, Buchan-Page, Rhodes, and Mr. Tan have reported no biomedical financial interests or potential conflicts of interest.
Funding Information:
This research was supported by National Institute of Mental Health (NIMH) grant #R01-MH100144 by Ohio State University College of Medicine Endowment and by a Clinical and Translational Science award 8UL18TR000090-05 from the National Center for Translational Sciences.Disclosure: Dr. Arnold has received research funding from Shire, Supernus, Otsuka, Roche/Genentech, and YoungLiving, has consulted with Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), Pfizer, and Waypoint, and has been on advisory boards for Ironshore, Novartis, Otsuka, Pfizer, Roche, and Shire (a Takeda company). Dr. Arns is unpaid research director of the Brainclinics Foundation, a minority shareholder in neuroCare Group (Munich, Germany); Brainclinics Foundation has received research funding from NIMH, Brain Resource (Sydney, Australia), UrgoTech and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn and Magventure. Dr. Barterian has received royalties from Springer Nature. Dr. Dasgupta has operated an integrative medicine clinic in Asheville, NC. Dr. deBeus has received research funding from NIMH, has served on the Board of Directors for the International Society for Neurofeedback and Research, and has a clinic in NC where he performs neurofeedback among other clinical services. Dr. Hirshberg is the Owner and Director of the NeuroDevelopment Center, Inc., which provides neurofeedback and other psychological services. Dr. Hollway has received research funding from F. Hoffman-La Roche, Supernus Pharmaceuticals, Young Living, the National Institutes of Health (NIH), and Autism Speaks. She has served on the YAMO Pharmaceuticals advisory board and has consulted with MedAvante-ProPhase for Finch Therapeutics. Dr. Kerson is Founder, CEO, and Director of Applied Psychophysiology Education (APEd). Dr. McBurnett has received research funding from Otsuka American Pharmaceutical, Akili Interactive, and American Bri-Vision and has served on the speakers? bureau for Ironshore. Dr. Monastra is the co-developer of the Thought Technology ADHD Assessment Suite and director of the FPI Attention Disorders Clinic. He has received equipment grants from Thought Technology and royalties from the Biofeedback Federation of Europe. He has received royalties for books and professional training videos on diagnosing and treating ADHD from the American Psychological Association. Dr. Roley-Roberts has received research funding from the American Psychological Foundation, the Foundation for Education and Research in Biofeedback and Related Sciences, the Foundation for Neurofeedback and Neuromodulation Research, NIMH, and NIH. Mr. Lightstone is founder and owner of EEG Software LLC. Drs. Black, Lofthouse, Lubar, Pan, Rice, Schrader, Williams, Mss. Bergman, Connor, Higgins, Buchan-Page, Rhodes, and Mr. Tan have reported no biomedical financial interests or potential conflicts of interest. Funding acquisition: Arnold
Funding Information:
This research was supported by National Institute of Mental Health (NIMH) grant #R01-MH100144 by Ohio State University College of Medicine Endowment and by a Clinical and Translational Science award 8UL18TR000090-05 from the National Center for Translational Sciences.